Resham Bhattacharya to Antineoplastic Agents
                            
                            
                                This is a "connection" page, showing publications Resham Bhattacharya has written about Antineoplastic Agents.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            2.458
         
        
        
     
 
    
        
        - 
            Reality CHEK: Understanding the biology and clinical potential of CHK1. Cancer Lett. 2021 01 28; 497:202-211.
            
            
                Score: 0.459
            
         
        
        - 
            Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer. Mol Cancer Ther. 2018 10; 17(10):2136-2143.
            
            
                Score: 0.394
            
         
        
        - 
            MDR1 mediated chemoresistance: BMI1 and TIP60 in action. Biochim Biophys Acta. 2016 08; 1859(8):983-93.
            
            
                Score: 0.341
            
         
        
        - 
            Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer. PLoS One. 2011 Mar 21; 6(3):e17918.
            
            
                Score: 0.237
            
         
        
        - 
            Role of hedgehog signaling in ovarian cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7659-66.
            
            
                Score: 0.202
            
         
        
        - 
            Induction of apoptosis in human cancer cell lines by diospyrin, a plant-derived bisnaphthoquinonoid, and its synthetic derivatives. Cancer Lett. 2002 Dec 15; 188(1-2):85-93.
            
            
                Score: 0.134
            
         
        
        - 
            Survival and SOS induction in cisplatin-treated Escherichia coli deficient in Pol II, RecBCD and RecFOR functions. DNA Repair (Amst). 2002 Nov 03; 1(11):955-66.
            
            
                Score: 0.133
            
         
        
        - 
            Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro. Int J Nanomedicine. 2020; 15:991-1003.
            
            
                Score: 0.110
            
         
        
        - 
            Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer. Mol Cancer Ther. 2018 01; 17(1):39-49.
            
            
                Score: 0.094
            
         
        
        - 
            Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics. Bioconjug Chem. 2014 Jun 18; 25(6):1078-90.
            
            
                Score: 0.074
            
         
        
        - 
            Probing novel roles of the mitochondrial uniporter in ovarian cancer cells using nanoparticles. J Biol Chem. 2013 Jun 14; 288(24):17610-8.
            
            
                Score: 0.069
            
         
        
        - 
            Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics. PLoS One. 2013; 8(3):e57522.
            
            
                Score: 0.068
            
         
        
        - 
            Designing nanoconjugates to effectively target pancreatic cancer cells in vitro and in vivo. PLoS One. 2011; 6(6):e20347.
            
            
                Score: 0.060
            
         
        
        - 
            MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017 05 22; 8:14634.
            
            
                Score: 0.023
            
         
        
        - 
            Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo. Int J Cancer. 2013 Mar 01; 132(5):1201-12.
            
            
                Score: 0.016
            
         
        
        - 
            Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev. 2012 Apr 07; 41(7):2943-70.
            
            
                Score: 0.016
            
         
        
        - 
            Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis. Proc Natl Acad Sci U S A. 2010 Aug 17; 107(33):14541-6.
            
            
                Score: 0.014
            
         
        
        - 
            Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev. 2010 Mar 08; 62(3):346-61.
            
            
                Score: 0.013